Terms: = Thyroid cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Diagnosis
93 results:
1. Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast cancer Society Clinical Practice Guidelines.
Hattori M; Honma N; Nagai S; Narui K; Shigechi T; Ozaki Y; Yoshida M; Sakatani T; Sasaki E; Tanabe Y; Tsurutani J; Takano T; Saji S; Masuda S; Horii R; Tsuda H; Yamaguchi R; Toyama T; Yamauchi C; Toi M; Yamamoto Y
Breast Cancer; 2024 May; 31(3):335-339. PubMed ID: 38433181
[TBL] [Abstract] [Full Text] [Related]
2. miRNA-449c-5p regulates the JAK-STAT pathway in inhibiting cell proliferation and invasion in human breast cancer cells by targeting erbb2.
Li L; Zhang Y; Yang K; Liu W; Zhou Z; Xu Y
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1974. PubMed ID: 38351535
[TBL] [Abstract] [Full Text] [Related]
3. thyroid Ultrasound Image Database and Marker Mask Inpainting Method for Research and Development.
Li X; Fu C; Xu S; Sham CW
Ultrasound Med Biol; 2024 Apr; 50(4):509-519. PubMed ID: 38267314
[TBL] [Abstract] [Full Text] [Related]
4. Contrast-Enhanced Ultrasound and Conventional Ultrasound Characteristics of Breast cancer With Different Molecular Subtypes.
Li X; Zhang J; Zhang G; Liu J; Tang C; Chen K; Chen P; Tan L; Guo Y
Clin Breast Cancer; 2024 Apr; 24(3):204-214. PubMed ID: 38102010
[TBL] [Abstract] [Full Text] [Related]
5. Profiling extracellular vesicle surface proteins with 10 µL peripheral plasma within 4 h.
He J; Li H; Mai J; Ke Y; Zhai C; Li JJ; Jiang L; Shen G; Ding X
J Extracell Vesicles; 2023 Sep; 12(9):e12364. PubMed ID: 37654045
[TBL] [Abstract] [Full Text] [Related]
6. Clinical characteristics and prognosis of postpartum breast cancer.
Paik PS; Choi JE; Lee SW; Lee YJ; Kang YJ; Lee HJ; Bae SY;
Breast Cancer Res Treat; 2023 Nov; 202(2):275-286. PubMed ID: 37542632
[TBL] [Abstract] [Full Text] [Related]
7. Lung cancer with breast metastasis: a case report and review of the literature.
Cao X; Chen P; Agyekum EA; Zhang Q; Qian X; Wu T; Chambers KH; Yin L
J Int Med Res; 2023 Jul; 51(7):3000605231188287. PubMed ID: 37523488
[TBL] [Abstract] [Full Text] [Related]
8. Evaluating the Correlation of Hedgehog Pathway with Claudin-1 Expression in Invasive Breast cancer.
Chen D; Cheng X
Cell Mol Biol (Noisy-le-grand); 2023 Feb; 69(2):60-66. PubMed ID: 37224045
[TBL] [Abstract] [Full Text] [Related]
9. Explore the diagnostic performance of 2020 Chinese thyroid Imaging Reporting and Data Systems by comparing with the 2017 ACR-TIRADS guidelines: a single-center study.
Cai M; Chen L; Shui L; Lv X; Wang H
Endocrine; 2023 May; 80(2):399-407. PubMed ID: 36930437
[TBL] [Abstract] [Full Text] [Related]
10. Primary salivary duct carcinoma of the lung: clinicopathological features, diagnosis and practical challenges.
Li S; Hou L; Huang Y; Wu W; Wu C; Zhang L
J Clin Pathol; 2024 Apr; 77(5):324-329. PubMed ID: 36697219
[TBL] [Abstract] [Full Text] [Related]
11. COMMD3-Mediated Endosomal Trafficking of her2 Inhibits the Progression of Ovarian Carcinoma.
Wang S; Liu Y; Li S; Chen Y; Liu Y; Yan J; Wu J; Li J; Wang L; Xiang R; Shi Y; Qin X; Yang S
Mol Cancer Res; 2023 Mar; 21(3):199-213. PubMed ID: 36445330
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic nomogram for female patients suffering from non-metastatic her2 positive breast cancer: A SEER-based study.
Wu J; Xie Z; Xiao Y; Wang B; Zhang P
Medicine (Baltimore); 2022 Oct; 101(40):e30922. PubMed ID: 36221419
[TBL] [Abstract] [Full Text] [Related]
13. Circular RNA circPRMT5 is upregulated in breast cancer and is required for cell proliferation and migration.
Li X; Zhang D; Feng Z; Xu X; Zhang J; Yu A; Zhu L; Xiao J; Du J; Chen M
Turk J Med Sci; 2022 Apr; 52(2):303-312. PubMed ID: 36161608
[TBL] [Abstract] [Full Text] [Related]
14. High in-vivo stability in preclinical and first-in-human experiments with [
Qin X; Guo X; Liu T; Li L; Zhou N; Ma X; Meng X; Liu J; Zhu H; Jia B; Yang Z
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):302-313. PubMed ID: 36129493
[TBL] [Abstract] [Full Text] [Related]
15. Absolute Lymphocyte Count as an Independent Prognostic Factor in Metastatic Breast cancer: A Retrospective Study.
Sawa A; Bando H; Kamohara R; Takeuchi N; Terasaki A; Okazaki M; Iguchi-Manaka A; Hara H
Oncology; 2022; 100(11):591-601. PubMed ID: 36099888
[TBL] [Abstract] [Full Text] [Related]
16. Effect of Previous cancer History on Survival of Patients with Different Subtypes of Breast cancer.
Lin W; Chen Y; Ji Z; Chen L; Wu J; Chen Y; Li Z
Biomed Res Int; 2022; 2022():6116658. PubMed ID: 36093405
[TBL] [Abstract] [Full Text] [Related]
17. The Effect of her2 Status on Metaplastic Breast cancer A Propensity Score-Matched Analysis.
Hu J; Zhang Y; Dong F; Shen J; Chen H; Li L; Huang T
Front Endocrinol (Lausanne); 2022; 13():874815. PubMed ID: 35928894
[TBL] [Abstract] [Full Text] [Related]
18. The initial expression alterations occurring to transcription factors during the formation of breast cancer: Evidence from bioinformatics.
Dong X; Yang Y; Xu G; Tian Z; Yang Q; Gong Y; Wu G
Cancer Med; 2022 Mar; 11(5):1371-1395. PubMed ID: 35037412
[TBL] [Abstract] [Full Text] [Related]
19. Risk Factors, Prognostic Factors, and Nomogram for Distant Metastasis in Breast cancer Patients Without Lymph Node Metastasis.
Min Y; Liu X; Hu D; Chen H; Chen J; Xiang K; Yin G; Han Y; Feng Y; Luo H
Front Endocrinol (Lausanne); 2021; 12():771226. PubMed ID: 34899606
[TBL] [Abstract] [Full Text] [Related]
20. Determinants of remission in a case series of medullary thyroid carcinoma.
Apaydın T; İmre E; Yavuz D
Turk J Med Sci; 2021 Aug; 51(4):2050-2056. PubMed ID: 33984892
[TBL] [Abstract] [Full Text] [Related]
[Next]
